Basal epithelial cells in prostate development, tumorigenesis, and cancer progression

被引:3
|
作者
Pitzen, Samuel P. [1 ,2 ]
Dehm, Scott M. [1 ,3 ,4 ,5 ]
机构
[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[2] Univ Minnesota, Grad Program Mol Cellular & Dev Biol & Genet, Minneapolis, MN USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Med Sch, Minneapolis, MN USA
[4] Univ Minnesota, Dept Urol, Minneapolis, MN USA
[5] Univ Minnesota, Masonic Canc Ctr, Mayo Mail Code 806,420 Delaware St SE, Minneapolis, MN 55455 USA
关键词
Prostate; basal epithelial cells; development; cancer; lineage plasticity; NEUROENDOCRINE CELLS; DIFFERENTIATION; CARCINOMA; ORGANOGENESIS; HISTOLOGY; PTEN; P63;
D O I
10.1080/15384101.2023.2206502
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prostate epithelium is composed of two predominant cell populations: luminal and basal epithelial cells. Luminal cells have a secretory function that supports male fertility while basal cells function in regeneration and maintenance of epithelial tissue. Recent studies in humans and mice have expanded our knowledge of the role and regulation of luminal and basal cells in prostate organogenesis, development, and homeostasis. The insights from healthy prostate biology can inform studies focused on the origins of prostate cancer, progression of the disease, and development of resistance to targeted hormonal therapies. In this review, we discuss a critical role for basal cells in the development and maintenance of healthy prostate tissue. Additionally, we provide evidence supporting a role for basal cells in oncogenesis and therapeutic resistance mechanisms of prostate cancer. Finally, we describe basal cell regulators that may promote lineage plasticity and basal cell identity in prostate cancers that have developed therapeutic resistance. These regulators could serve as therapeutic targets to inhibit or delay resistance and thereby improve outcomes for prostate cancer patients.
引用
收藏
页码:1303 / 1318
页数:16
相关论文
共 50 条
  • [1] Basal prostate epithelial cells stimulate the migration of prostate cancer cells
    Yu, HM
    Frank, DE
    Zhang, J
    You, XK
    Carter, WG
    Knudsen, BS
    MOLECULAR CARCINOGENESIS, 2004, 41 (02) : 85 - 97
  • [2] Epithelial Stem Cells of the Prostate and Their Role in Cancer Progression
    Lukacs, R. U.
    Lawson, D. A.
    Xin, L.
    Zong, Y.
    Garraway, I.
    Goldstein, A. S.
    Memarzadeh, S.
    Witte, O. N.
    CONTROL AND REGULATION OF STEM CELLS, 2008, 73 : 491 - +
  • [3] Basal epithelial stem cells are efficient targets for prostate cancer initiation
    Lawson, Devon A.
    Zong, Yang
    Memarzadeh, Sanaz
    Xin, Li
    Huang, Jiaoti
    Witte, Owen N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (06) : 2610 - 2615
  • [4] The role of stromal cells in prostate cancer development and progression
    Condon, MS
    Bosland, MC
    IN VIVO, 1999, 13 (01): : 61 - 65
  • [5] Comment on basal epithelial stem cells as efficient targets for prostate cancer initiation
    Wong, Letitia
    Bushman, Wade
    STEM CELL RESEARCH & THERAPY, 2010, 1
  • [6] Comment on basal epithelial stem cells as efficient targets for prostate cancer initiation
    Letitia Wong
    Wade Bushman
    Stem Cell Research & Therapy, 1
  • [7] Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice
    Reiner, Teresita
    de las Pozas, Alicia
    Parrondo, Ricardo
    Perez-Stable, Carlos
    MOLECULAR CANCER RESEARCH, 2007, 5 (11) : 1171 - 1179
  • [8] Changes in gene expression of stromal and epithelial cells during prostate cancer progression
    Babic, Milos
    Imler, Elliot
    Shepard, Peter
    Yeakley, Joanne
    Nagle, Raymond
    Seligmann, Bruce
    CANCER RESEARCH, 2017, 77
  • [9] Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer
    Zhu, Jialin
    Yang, Xueling
    Wang, Yan
    Zhang, Haonan
    Guo, Zhi
    ONCOLOGY LETTERS, 2019, 17 (06) : 5094 - 5102
  • [10] Prostate cancer from basal cells
    Kirk R.
    Nature Reviews Clinical Oncology, 2010, 7 (10) : 550 - 550